Molecular Screening for Hepatitis Virus

HBV can cause acute and chronic infection. There is currently no role for molecular testing in the diagnosis of acute hepatitis B other than in the detection of asymptomatic patients during pretransfusion screening of blood products. To facilitate an understanding of the utility of molecular testing for chronic hepatitis B, the four stages of chronic hepatitis B infection that are currently recognized, as well as an additional entity, occult hepatitis B, that can be diagnosed only by sensitive nucleic acid amplification methods, are reviewed in detail, including available therapeutic age

  • Serological and molecular testing
  • Laboratory methods for Diagnosis & management
  • Current molecular methods

  • Serological
  • Laboratory methods for Diagnosis & management
  • Molecular testing

Related Conference of Molecular Screening for Hepatitis Virus

May 26-26, 2021

International Conference on Hepatitis

London, UK
June 14-15, 2021

7th International Conference on Hepatology

Osaka, Japan
June 14-15, 2021

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
June 14-15, 2021

International Congress on Viral Hepatitis

Rome, Italy
July 13-14, 2021

International Conference on Hepatitis & Liver diseases

Shanghai, Australia
July 20-21, 2021

20th World Gastroenterologists Summit

Osaka, Japan
August 05-06, 2021

Global Congress on Pancreas

Zurich, Switzerland
September 27-28, 2021

8th Global Conference on Mass Spectrometry

Tokyo, Japan
September 28-29, 2021

2 nd World Congress on Oil and Gas Engineering

Auckland, Newzealand
November 23-24, 2021

World Conference on Digestive and metabolic diseases

Hanoi, Vietnam

Molecular Screening for Hepatitis Virus Conference Speakers

Recommended Sessions

Related Journals

Are you interested in